BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 33456585)

  • 1. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.
    Han Z; Wang X; Xu Z; Cao Y; Gong R; Yu Y; Yu Y; Guo X; Liu S; Yu M; Ma W; Zhao Y; Xu J; Li X; Li S; Xu Y; Song R; Xu B; Yang F; Bamba D; Sukhareva N; Lei H; Gao M; Zhang W; Zagidullin N; Zhang Y; Yang B; Pan Z; Cai B
    Theranostics; 2021; 11(6):3000-3016. PubMed ID: 33456585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 and ALKBH5 oppositely regulate m
    Song H; Feng X; Zhang H; Luo Y; Huang J; Lin M; Jin J; Ding X; Wu S; Huang H; Yu T; Zhang M; Hong H; Yao S; Zhao Y; Zhang Z
    Autophagy; 2019 Aug; 15(8):1419-1437. PubMed ID: 30870073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging-Associated ALKBH5-m
    Chen R; Zhang G; Sun K; Chen AF
    J Am Heart Assoc; 2024 Jan; 13(1):e031353. PubMed ID: 38156523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction.
    Gao X; Liang X; Liu B; Hong Y; He H; Shen Y; Chen J; Huang X; Hu B; Li W; Li X; Zhang Y
    FASEB J; 2023 Dec; 37(12):e23294. PubMed ID: 37966425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    Yang Z; Cai Z; Yang C; Luo Z; Bao X
    EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALKBH5 attenuates mitochondrial fission and ameliorates liver fibrosis by reducing Drp1 methylation.
    Wang J; Yang Y; Sun F; Luo Y; Yang Y; Li J; Hu W; Tao H; Lu C; Yang JJ
    Pharmacol Res; 2023 Jan; 187():106608. PubMed ID: 36566000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A.
    Zhao Y; Hu J; Sun X; Yang K; Yang L; Kong L; Zhang B; Li F; Li C; Shi B; Hu K; Sun A; Ge J
    Clin Transl Med; 2021 May; 11(5):e402. PubMed ID: 34047466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting axon regeneration by inhibiting RNA N6-methyladenosine demethylase ALKBH5.
    Wang D; Zheng T; Zhou S; Liu M; Liu Y; Gu X; Mao S; Yu B
    Elife; 2023 Aug; 12():. PubMed ID: 37535403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair.
    Ponnusamy M; Liu F; Zhang YH; Li RB; Zhai M; Liu F; Zhou LY; Liu CY; Yan KW; Dong YH; Wang M; Qian LL; Shan C; Xu S; Wang Q; Zhang YH; Li PF; Zhang J; Wang K
    Circulation; 2019 Jun; 139(23):2668-2684. PubMed ID: 30832495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
    Zhang L; Su X
    Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.
    Tang C; Klukovich R; Peng H; Wang Z; Yu T; Zhang Y; Zheng H; Klungland A; Yan W
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E325-E333. PubMed ID: 29279410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.
    Sun Z; Su Z; Zhou Z; Wang S; Wang Z; Tong X; Li C; Wang Y; Chen X; Lei Z; Zhang HT
    FASEB J; 2022 May; 36(5):e22283. PubMed ID: 35344216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RNA demethylase ALKBH5 promotes osteoblast differentiation by modulating Runx2 mRNA stability.
    Feng L; Fan Y; Zhou J; Li S; Zhang X
    FEBS Lett; 2021 Aug; 595(15):2007-2014. PubMed ID: 34105773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
    Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
    Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBM33 is a unique m
    Yu F; Zhu AC; Liu S; Gao B; Wang Y; Khudaverdyan N; Yu C; Wu Q; Jiang Y; Song J; Jin L; He C; Qian Z
    Mol Cell; 2023 Jun; 83(12):2003-2019.e6. PubMed ID: 37257451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.